Issued Patents All Time
Showing 25 most recent of 107 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11697635 | Procedure for crystallization of (22E)-(24R)-2-methylene-22-dehydro-1α,24-25-trihydroxy-19-nor-vitamin D3 | Hector F. DeLuca, Margaret Clagett-Dame, Agnieszka Flores, James B. Thoden, Hazel Holden | 2023-07-11 |
| 11266664 | Use of homosalate and octyl salicylate to treat multiple sclerosis | Hector F. DeLuca, Steven Marling, Yanping Wang | 2022-03-08 |
| 10494337 | (20S)-1-α,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharmaceutical uses | Hector F. DeLuca, Agnieszka Flores, Hazel Holden, James B. Thoden | 2019-12-03 |
| 10479764 | 2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs | Hector F. DeLuca, Margaret Clagett-Dame, Rafal Barycki | 2019-11-19 |
| 10434110 | Use of homosalate and octyl salicylate to treat multiple sclerosis | Hector F. DeLuca, Steven Marling, Yanping Wang | 2019-10-08 |
| 10369161 | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism | Hector F. DeLuca, Margaret Clagett-Dame | 2019-08-06 |
| 10105375 | Combination of low dose 2-methylene-19-nor-(20S)1α, 25-dihydroxyvitamin D3 and calcimimetics to treat secondary hyperparathyroidism | Hector F. DeLuca, Margaret Clagett-Dame | 2018-10-23 |
| 10046000 | Use of 2-methylene-19-nor-(20S)-1α,25-Dihydroxyvitamin D3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure | Hector F. DeLuca, Julia B. Zella, Margaret Clagett-Dame | 2018-08-14 |
| 9834512 | (22E)-2-methylene-26,27-cyclo-22-dehydro-1α-hydroxy-19-norvitamin D3 derivatives | Hector F. DeLuca, Rafal Barycki, Margaret Clagett-Dame | 2017-12-05 |
| 9814736 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 and calcimimetics to treat secondary hyperparathyroidism | Hector F. DeLuca, Margaret Clagett-Dame | 2017-11-14 |
| 9717744 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof | Hector F. DeLuca, Julia B. Zella, Margaret Clagett-Dame | 2017-08-01 |
| 9688596 | Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds | Hector F. DeLuca, Izabela Sibilska, Rafal R. Sicinski | 2017-06-27 |
| 9539264 | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics | Hector F. DeLuca, Margaret Clagett-Dame | 2017-01-10 |
| 9416102 | (22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs | Hector F. DeLuca, Rafal Barycki, Margaret Clagett-Dame | 2016-08-16 |
| 9339509 | Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog with or without a retinoid | Margaret Clagett-Dame, Hector F. DeLuca, Nircaq J. Nieves, Mary E. Kaiser | 2016-05-17 |
| 9290447 | (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses | Hector F. DeLuca, Margaret Clagett-Dame, Rafal Barycki | 2016-03-22 |
| 9212137 | Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors | Hector F. DeLuca, Pawel Grzywacz, Agnieszka Flores, James B. Thoden, Hazel Holden | 2015-12-15 |
| 9205096 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism | Hector F. DeLuca, Julia B. Zella, Margaret Clagett-Dame | 2015-12-08 |
| 9034853 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism | Hector F. DeLuca, Julia B. Zella, Margaret Clagett-Dame | 2015-05-19 |
| 8993547 | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses | Hector F. DeLuca, Rafal R. Sicinski, Izabela Sibilska, Margaret Clagett-Dame | 2015-03-31 |
| 8987235 | N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses | Hector F. DeLuca, Margaret Clagett-Dame, Grazia Chiellini | 2015-03-24 |
| 8785422 | A-ring modified 19-nor-vitamin D analogs and their uses | Hector F. DeLuca, Margaret Clagett-Dame, Agnieszka Glebocka | 2014-07-22 |
| 8759328 | Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration | Hector F. DeLuca, Margaret Clagett-Dame | 2014-06-24 |
| 8754067 | 22-haloacetoxy-homopregnacalciferol analogs and their uses | Hector F. DeLuca, Rafal Barycki | 2014-06-17 |
| 8729054 | 3-desoxy-2-methylene-vitamin D analogs and their uses | Hector F. DeLuca, Rafal R. Sicinski, Izabela Sibilska | 2014-05-20 |